Overnight Digest: Stocks to keep an eye on August 29

Overnight Digest: Stocks to keep an eye on August 29

Sayali Kotwal
/ Categories: Trending, Mindshare

Keep a watch on these stocks for Monday's trading session

The domestic indices had a great start to the day but gave up the majority of the gains to end flat. With the exception of BSE Realty and BSE FMCG, almost all the other sectors were trading higher. With gains of over 1 per cent each, BSE Metals and BSE Consumer Durables were the top performing sectors.  

At the time of market closing, Sensex was at 58,833 level, gaining 59 points or 0.10 per cent while Nifty 50 was at 17,558, inching higher by 36 points or 0.21 per cent.  

In BSE 200 Group, the shares of ABB India, Bajaj Auto, Bank of Baroda, Eicher Motors, Coal India, and Adani Transmission have made their respective fresh 52-week highs today.  

Keep a watch on these stocks for Monday's trading session: 

Titan Company: Jewellery giant Titan has detailed a retail development plan with an eye toward the Indian diaspora. C K Venkataraman, MD of Titan announced during the launch of a campaign on Thursday that the company would open 20 to 30 Tanishq outlets in the next two to three years throughout the Middle East and North America. While introducing ‘Titan Shaurya’, Venkataraman stated that the company anticipates its sales to increase by 15 per cent -20 per cent this holiday season compared to the previous year. The shares of Titan closed at Rs 2,532.50 a piece on BSE today.   

 

HDFC Bank: In order to acquire a roughly 10 per cent stake in Go Digit Life Insurance, which is owned by the owners of Go Digit General Insurance, India's largest private lender said that it would invest between Rs 49.9 crore and Rs 69.9 crore. The lender's shares had favourable trading but ahead of a speech by US Fed Chairman Jerome Powell, Dalal Street continues to be cautious about the banking sector. The shares of HDFC Bank closed at Rs 1,463.40 a piece on BSE today.  

Dr Reddy’s Laboratories: For its Srikakulam facility, the company has obtained an establishment inspection report (EIR). United States Food & Drug Administration (USFDA) inspected the formulations manufacturing facility (FTO 11) in Srikakulam, (Andhra Pradesh), the business disclosed in July. The agency has now declared the inspection to be ‘closed’. Following the news, the shares of Dr Reddy’s Laboratories closed 0.60 per cent lower on BSE today.  

Previous Article Stocks to watch: These small-cap stocks will be in focus on Monday!
Next Article What is the difference between Mainboard IPO and SME IPO?
Rate this article:
4.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR